|
Company Profile
Group Structure
Business Review
Milestones
Honors
Cultures
Overseas Cooperation

 

Milestones

 
Year 2006

According to statistics from the “Pharmaceutical Industry Bulletin” issued by China Pharmaceutical Industry Association in 2006, Suzhou Dawnrays Pharmaceutical Co., Ltd. was ranked at the 42nd spot in terms of total profit as an individual entity.

In April

Construction of a new warehouse of Suzhou Dawnrays Pharmaceutical Co., Ltd. which covers a construction area of approximately 4,100 m2 was completed and was under operation.

In May

Suzhou Dawnrays Chemical Co., Ltd. has successfully passed the examination and attestation on three major Management System as conducted by American Quality Assessors International, LLC (AQA International, LLC), an accredited organization in the United States.

In June Construction of a pilot production workshop of Suzhou Dawnrays Chemical Co., Ltd. was completed and was under operation.
In June

The re-construction project for re-location and expansion of sterile bulk medicine workshops no. 101 and 102 of Suzhou Dawnrays Pharmaceutical Co., Ltd. was fixed.

In November Dawnrays Pharmaceutical Group held the third training camp for Managers.
In December

Re-construction of a workshop for cephalosporin tablets of Suzhou Dawnrays Pharmaceutical Co., Ltd. was completed.

In December Dawnrays (Nantong) Pharmaceutical Science and Technology Co., Ltd. was invested by the Group and established in Nantong, Jiangsu Province. A piece of land at approximately 130 mu (about 8.7 hectares) was acquired for a new project.
Year 2005

According to statistics from the “Pharmaceutical Industry Bulletin” issued by China Pharmaceutical Industry Association in 2005, Suzhou Dawnrays Pharmaceutical Co., Ltd. was ranked at the 28th spot in terms of total profit as an individual entity.

In May

Mr. JIN Hailong, Mayor of Wuzhong District, Suzhou together with other senior officials visited Suzhou Dawnrays Pharmaceutical Co., Ltd. for investigation and study.

In July

The new sterile bulk medicine workshop no. 104 and the workshop no. 102 which incorporated a new product Cefuroxime Sodium of Suzhou Dawnrays Pharmaceutical Co., Ltd., passed the GMP certification from the State Food and Drug Administration (SFDA).

In September Dawnrays Pharmaceutical Group participated in the planning of the Wuzhong District Charity Federation and Ms. LI Kei Ling, the company's Chairman was served as the council member of the first council.
In October

Dawnrays Pharmaceutical Group held the second training camp for Managers.

In December

Dawnrays Pharmaceutical Group organized a series of activities for its tenth anniversary celebration.

In December Mr. YAN Li and Mr. ZHAO Junsheng, Mayor and Deputy Mayor of Suzhou respectively, together with other senior officials made an inspection tour to Suzhou Dawnrays Chemical Co., Ltd. with respect to the safety of the production work.
Year 2004

According to statistics from the “China Pharmaceutical Statistics Report 2003” (Pharmaceutical Chemical section), Suzhou Dawnrays Pharmaceutical Co., Ltd. was ranked at the 31st and the 13th spots among the nation's top 400 pharmaceutical enterprises in the Pharmaceutical Chemical section of individual entities in terms of sales income and total profit respectively.

In May

Mr. LI Quanlin, Deputy Governor of Jiangsu Province visited Suzhou Dawnrays Pharmaceutical Co., Ltd.

In June

Suzhou Dawnrays Pharmaceutical Co., Ltd. successfully passed the GMP re-inspection.

In July Mr. YU Guangzhou, Vice Minister of Commerce visited Suzhou Dawnrays Pharmaceutical Co., Ltd. for investigation and study.
In September

Mr. Wu Changrui, Mr. WANG Daowu, Mr. JIANG Wentao and Mr. WANG Qi from the Jiangsu Science and Technology Committee of Chinese People's Political Consultative Conference and other committee members visited Suzhou Dawnrays Pharmaceutical Co., Ltd. for an inspection tour.

In October

Dawnrays Pharmaceutical Group held the first training camp for Managers.

In December Party cadres from the Government of Yinzhou District, Ningbo, Zhejiang Province visited Suzhou Dawnrays Pharmaceutical Co., Ltd. for an investigation tour.
Year 2003

According to statistics from the “China Pharmaceutical Statistics Report 2002” (Pharmaceutical Chemical section), Suzhou Dawnrays Pharmaceutical Co., Ltd. was ranked at the 69th and the 26th spots among the nation's top 400 pharmaceutical enterprises in the Pharmaceutical Chemical section of individual entities in terms of sales income and total profit respectively.

On July 11th Dawnrays Pharmaceutical (Holdings) Ltd. was successfully listed on the Main Board of the Stock Exchange of Hong Kong. Suzhou Dawnrays Pharmaceutical Co., Ltd. as a core subsidiary of the Group, being the first enterprise in Suzhou, as well as the first pharmaceutical enterprise in Jiangsu Province listed on the Main Board of the Stock Exchange of Hong Kong.
On July 25th

Dawnrays Pharmaceutical Group held a press release conference in Dong Shan Hotel for the successful IPO of Dawnrays Pharmaceutical (Holdings) Ltd. on the Main Board of the Stock Exchange of Hong Kong.

On August 23rd According to the Market Information page of “China Pharmaceutical News”, Suzhou Dawnrays Pharmaceutical Co., Ltd. was ranked at the 83rd spot among the nation's top 100 pharmaceutical industrial enterprises in terms of product sales income for the first half of the year 2003.
In October

Mr. WANG Min, member of the Standing Committee of Jiangsu Province and the Party Secretary of the Suzhou Municipal Committee, visited Suzhou Dawnrays Pharmaceutical Co., Ltd.

In November

Mr. YANG Weize, Mayor of Suzhou, visited Suzhou Dawnrays Pharmaceutical Co., Ltd. for investigation and study.

In December Suzhou Dawnrays Pharmaceutical Co., Ltd. increased its share capital to the registered amount of USD 25 million.
Year 2002

According to statistics from the “China Pharmaceutical Statistics Report 2001” (Pharmaceutical Chemical section), Suzhou Dawnrays Pharmaceutical Co., Ltd. was ranked at the 128th and the 41st spots among the nation's top 400 pharmaceutical enterprises in the Pharmaceutical Chemical section of individual entities in terms of sales income and total profit respectively.

In October

Phase II of the construction project of Suzhou Dawnrays Pharmaceutical Co., Ltd. has initiated with the estimated total capital expenditure of USD 19 million.

In December

Dawnrays Pharmaceutical Group invested USD 1.7 million to register as a solely foreign-invested enterprise named Suzhou Dawnrays Chemical Co., Ltd. in Wuzhong Economic Development District of Suzhou.

Year 1998
In January Suzhou Dawnrays Pharmaceutical Co., Ltd. was granted the GMP certificate.
In April Suzhou Dawnrays Pharmaceutical Co., Ltd. started its trial production.
In August Suzhou Dawnrays Pharmaceutical Co., Ltd. donated RMB 1 million worth of the first batch of pharmaceutical products to the frontline of the flood fight.
In August

Suzhou Dawnrays Pharmaceutical Co., Ltd. obtained 8 production permits for its pharmaceutical products, such as Cefoperazone Sodium for Injection and Cetirizine Hydrochloride Tablets, etc. Sales network and team were developed.

Year 1997
In October

Phase I of the construction project of Suzhou Dawnrays Pharmaceutical Co., Ltd. was completed.

In December

Dawnrays Pharmaceutical Group funded to establish Sino-foreign joint venture – Shanghai Dawnrays Chemical Co., Ltd.

In December

Suzhou Dawnrays Pharmaceutical Co., Ltd. successfully passed the overall inspection for GMP certification of pharmaceutical products conducted by the State Food and Drug Administration (SFDA).

Year 1995
On December 8th

Suzhou Dawnrays Pharmaceutical Co., Ltd. was founded and being issued with a Corporate Legal Person Business License.